Amanote Research
Register
Sign In
BRAF G596R Mutation in a Slow-Progressing Melanoma
Pathology and Laboratory Medicine International
doi 10.2147/plmi.s88369
Full Text
Open PDF
Abstract
Available in
full text
Date
August 1, 2015
Authors
Deqin Ma
Ling Gao
Publisher
Informa UK Limited
Related search
Which Melanoma Patient Carries a BRAF-mutation? A Comparison of Predictive Models
Oncotarget
Oncology
A Case of Primary Gastric Melanoma Exhibiting a Rare BRAF V600R Mutation
European Journal of Case Reports in Internal Medicine
Internal Medicine
Proteomic Profile and in Silico Analysis in Metastatic Melanoma With and Without BRAF Mutation
PLoS ONE
Multidisciplinary
Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
BRAF Mutation as a Biomarker in Colorectal Cancer
Advances in Genomics and Genetics
Treating Malignant Melanoma When a Rare BRAF V600M Mutation Is Present: Case Report and Literature Review
Romanian Journal of Internal Medicine
Medicine
Accelerated BRAF Mutation Analysis Using a Fully Automated PCR Platform Improves the Management of Patients With Metastatic Melanoma
Oncotarget
Oncology
BRAF,NRASandKITsequencing Analysis of Spindle Cell Melanoma
Journal of Cutaneous Pathology
Dermatology
Forensic Medicine
Pathology
Histology
Beyond BRAF: Where Next for Melanoma Therapy?
British Journal of Cancer
Cancer Research
Oncology